nafronyl has been researched along with Kidney Calculi in 2 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Kidney Calculi: Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.
Excerpt | Relevance | Reference |
---|---|---|
"5 years) of whom 49 had been treated orally with naftidrofuryl oxalate at a mean dosage of 485 +/- 120 mg/24h." | 1.29 | Calcium oxalate crystalluria in elderly patients and treatment with naftidrofuryl oxalate. ( Bouthier, F; Charmes, JP; Leroux-Robert, C; Moesch, C, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moesch, C | 1 |
Charmes, JP | 1 |
Bouthier, F | 1 |
Leroux-Robert, C | 1 |
Retornaz, F | 1 |
Jean-Pastor, MJ | 1 |
Monestier, S | 1 |
Durand, JM | 1 |
Soubeyrand, J | 1 |
2 other studies available for nafronyl and Kidney Calculi
Article | Year |
---|---|
Calcium oxalate crystalluria in elderly patients and treatment with naftidrofuryl oxalate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Calcium Oxalate; Crystallization; Dose-Response Relat | 1995 |
Recurrent calcium oxalate nephrolithiasis induced by naftidrofuryl oxalate.
Topics: Calcium Oxalate; Female; Humans; Kidney Calculi; Middle Aged; Nafronyl; Parasympatholytics; Recurren | 2000 |